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Primary Antiphospholipid Antibody
Syndrome: Neuroradiologic
Findings in 11 Patients
Objective: To describe the neuroradiologic findings of primary antiphospholipid
antibody syndrome (PAPS).
Materials and Methods: During a recent two-year period, abnormally elevated
antiphospholipid antibodies were detected in a total of 751 patients. In any cases
in which risk factors for stroke were detected - hypertension, diabetes mellitus,
hyperlipidemia, smoking, and the presence of SLE or other connective tissue dis-
eases - PAPS was not diagnosed. Neuroradiologic studies were performed in 11
of 32 patients with PAPS. We retrospectively reviewed brain CT (n = 7), MR (n =
8), and cerebral angiography (n = 8) in 11 patients with special attention to the
presence of brain parenchymal lesions and cerebral arterial or venous abnormali-
ties. 
Results: CT or MR findings of PAPS included nonspecific multiple hyper-inten-
sity foci in deep white matter on T2-weighted images (5/11), a large infarct in the
territory of the middle cerebral artery (4/11), diffuse cortical atrophy (2/11), focal
hemorrhage (2/11), and dural sinus thrombosis (1/11). Angiographic findings
were normal (5/8) or reflected either occlusion of a large cerebral artery (2/8) or
dural sinus thrombosis (1/8).
Conclusion: Neuroradiologic findings of PAPS are nonspecific but in young or
middle- aged adults who show the above mentioned CT or MR findings, and in
whom risk factors for stroke are not present, the condition should be suspected.
n 1986, Harris et al. (1) proposed criteria for a new clinical syndrome
characterized by unexplained recurrent venous or arterial thrombosis, fe-
tal loss occuring more than twice, or thrombocytopenia in the presence of
autoantibodies to phospholipids such as anticardiolipin antibody and lupus anticoagu-
lant. Approximately one half of patients with antiphospholipid antibody syndrome do
not have associated systemic lupus erythematosus (SLE) or other collagen vascular dis-
ease, and such cases were classified as primary antiphospholipid antibody syndrome
(PAPS) (1 4). During the past ten years, it has become clear that the thrombosis associ-
ated with antiphospholipid antibodies is a major cause of organ damage in PAPS, SLE
and other autoimmune diseases (5). Early descriptions of PAPS were published largely
in the rheumatology literature.
Cases involving variable sized infarctions, diffuse cortical atrophy, white matter ab-
normality, and dural sinus thrombosis in patients with PAPS have been reported in the
radiologic literature (6, 7). In this study, we reviewed the neuroradiologic findings in
11 Korean patients in whom PAPS was diagnosed, and compared our observations
with previous reports.
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IMATERIALS AND METHODS
We reviewed the results of laboratory tests for the pres-
ence of lupus anticoagulant and anticardiolipin antibody
performed between May 1995 and May 1997. The lupus
anticoagulant test included prothrombin time, active par-
tial thromboplastin time, the tissue thromboplastin inhibi-
tion test, thrombin clot time, and a diluted Russell viper
venom time. Anticardiolipin antibody (IgG and IgM) deter-
mination involved the use of enzyme-linked immunosor-
bent assay (ELISA). Antiphospholipid antibodies were de-
tected in 751 of 3250 tested patients. Of these 751, 361
showed elevated anticardiolipin levels, 239 showed abnor-
mal lupus anticoagulants, and the remaining 151 showed
elevation of both antibodies. We used the diagnostic crite-
ria proposed by Harris et al. (1, 2), which include recurrent
thrombosis, more than two spontaneous abortions, and el-
evated lupus anticoagulant or anticardiolipin antibody on
two occasions more than eight weeks apart. When patients
fulfilled the Harris criteria and had no other risk factors for
vascular thrombosis or occlusion (hypertension, diabetes
mellitus, hyperlipidemia, smoking, SLE or other connective
tissue diseases), PAPS was diagnosed. Patients with elevat-
ed lupus anticoagulant or anticardiolipin antibody and oth-
er risk factors for vascular thrombosis or occlusion were
excluded, and PAPS was confirmed in the 32 patients who
remained. Eleven of these underwent neuroradiologic 
studies to evaluate symptoms such as hemiplegia (n = 6),
headache (n = 3), dementia (n = 1), and memory distur-
bance (n = 1). 
Brain CT was performed in seven patients according to
our routine brain CT protocol: slice thickness, 5 10 mm;
FOV, 210 mm; standard alogorithm; scan time, 2 sec.
Using a 1.5-T system (General Electric Medical Systems,
Milwau-kee, WI, version 5.4), brain MR was performed in
eight patients according to our routine brain MR protocol:
axial and sagittal spin-echo T1-weighted images, axial fast
spin-echo T2-weighted images (TR/TE, 420/14 msec for
T1-weighting, 3500/99 msec for T2-weighting; slice thick-
ness/gap, 6 7/2.4 2.8 mm; FOV, 200 250mm; matrix
size, 256 or 512). In four patients, axial and coronal T1-
weighted images were obtained after intravenous injection
of gadolinium-DTPA (0.1mmol/kg). In one patient, fluid
attenuated inversion recovery images (FLAIR; TR/TI/TE,
9999/2500/119 msec) were obtained in addition to fast
spin-echo T2-weighted images. To evaluate cerebral vascu-
lar status of eight patients, cerebral angiography was per-
formed using a digital subtraction biplane angiography sys-
tem (Integris BN 3000; Philips Medical Systems,
Eindhoven, Netherlands) via transfemoral route. 
The 11 patients comprised five men and six women
whose ages ranged between 20 and 60 (mean, 39) years.
Imaging studies were retrospectively reviewed by two ra-
diologists (JHK, CGC), who worked together. CT and MR
studies were reviewed, with special attention to the signal
or attenuation characteristics and location of lesions, and 
presence of hemorrhage. Angiographic studies were re-
viewed with special attention to obstruction or filling de-
fects in the intracranial vessels.
RESULTS
The symptoms and imaging features of the 11 patients
are summarized in Table 1. Six showed acute neurologic
symptoms and signs of hemiplegia while the other 5 com-
plained of chronic neurologic symptoms such as headache,
dementia, sensory change, and general weakness.
Abnormal brain CT findings were a large territorial infarct
(3/7), low densities of periventricular white matter (2/7),
focal hemorrhage in the basal ganglia (1/7), and dural sinus
thrombosis (1/7). MR findings were multiple hyper-intensi-
ty foci in the deep white matter on T2-weighted images
(5/8), a large territorial infarct (2/8), diffuse cortical atro-
phy (2/8), focal hemorrhage in the basal ganglia (1/8), and
dural sinus thrombosis (1/8). Angiographic findings were
normal (5/8), or reflected either occlusions of the middle
cerebral artery (2/8) or dural sinus thrombosis (1/8).
Multiple hyper-intensity foci in the deep white matter
seen on T2-weighted MR images or low densities in the
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Fig. 1. A 47-year-old man who at the time of examination had
suffered headache and general weakness for one month(case 4).
Axial T2-weighted MR image shows multiple high signal intensi-
ties(arrows) in the white matters at the level of the centrum semi-
ovale.Primary Antiphospholipid Antibody Syndrome
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Fig. 2. A 32-year-old man who reported the onset of hemiplegia three hours prior to examination (case 2).
A. Contrast-enhanced CT scan shows subtle low density in the right temporal lobe and insular cortex(arrows), suggesting a hyper-acute
infarct in the territory of the right middle cerebral artery.
B. Frontal view of right internal carotid angiogram shows complete occlusion of the right middle cerebral artery at M1 portion(arrow). 
Table 1. Summary of Clinical Manifestations and Neuroradiologic Findings of Primary Antiphospholipid Antibody Syndrome
Sex Clinical  Thrombo-
No /Age Manifestation, LA aCL cytopenia CT MR Angiography
Duration
10 M/28 Hemiplegia, Aphagia, + No Large MCA territorial infarction  Occlusion in left MCA
1 day
9 M/32 Hemiplegia, 1 day+ Yes Large MCA territorial infarction  Large MCA territorial infarction, Occlusion in right MCA
Focal hemorrhage at basal ganglia
5 M/45 Hemiplegia, 1 day+ Yes Large MCA territorial infarction 
4 M/47 Headache, 1 month + Yes Low density at PVWM Abnormal HIS at PVWM on T2WI Normal
8 M/55 Memory disturbance, +N o Abnormal HIS at PVWM on T2WI Normal
1 month
6 F/25 Hemiplegia, 2 days + Yes Dural sinus thrombosis in the Dural sinus thrombosis in Dural sinus thrombosis
superior sagittal sinus the superior sagittal, in the superior sagittal,
right transverse, right transverse,
and sigmoid sinus. and sigmoid sinus.
3 F/32 Headache, 1 year + + No Cortical atrophy,
Abnormal HIS at PVWM on T2WI
1 F/34 Dementia, 4 years + + Yes Cortical atrophy,
Abnormal HIS at PVWM on T2WI Normal
11 F/35 Hemiplegia, 1 day+ + No Large MCA territorial infarction 
7 F/40 Hemiplegia, 2 days + No Low density at PVWM Abnormal HIS at PVWM on T2WI Normal
2 F/60 Hemiplegia, 1 day+ + No Focal hemorrhage
at right basal ganglia Normal
Note.─ HIS = high signal intensity, PVWM = periventricular white matter, LA = lupus anticoagulant, aCL = anticardiolipin antibody, MCA = middle cerebral arteryperiventricular white matter seen on CT were the most
common findings, and were detected in five of eleven pa-
tients (Fig. 1). Cerebral angiography was normal in four of
these five patients. A large infarct in the territory of the
middle cerebral artery seen on CT and MR was the second
most common findings (4/11). In two of such patients,
abrupt cut-off of the corresponding middle cerebral arter-
ies was detected by cerebral angiography (Fig. 2), though
echocardiography revealed no risk of cardiogenic em-
bolism. MR demonstrated diffuse cortical atrophy in two
patients (Fig. 3), and in these two, T2-weighted MR images
showed multiple hyper-intensity foci in the deep white
matter. Cerebral angiography, performed in one of these 
two patients, demonstrated normal findings. Focal hemor-
rhage in the basal ganglia was detected in two patients. In
one patient with a focal hemorrhagic and edematous lesion
in left rolandic area, CT, MR and angiography indicated
the presence of dural sinus thrombosis (Fig. 4). In this pa-
tient, cerebral angiography revealed filling defects in the
superior sagittal, right transverse, and sigmoid sinus. 
DISCUSSION
In our study, multiple small lesions in the deep white
matter were the most common findings. Multiple hyper-in-
tensity foci in the deep white matter seen on T2-weighted
MR images or low densities in the periventricular white
matter revealed by CT are nonspecific findings. These ab-
normalities are similar to those seen in many demyelinat-
ing, inflammatory, or vascular diseases of the brain such as
multiple sclerosis, SLE, Behcet s disease, Sjogren s synd-
rome, migraine, and small vessel atherosclerotic disease. 
Provenzale et al. (6, 7) reported multiple small lacunar
infarcts or white matter abnormalities as one of the most
common findings in patients with brain involvement of
PAPS. Toubi et al. (8) found antiphospholipid antibody im-
munoreactivity in 55% of SLE patients with CNS manifes-
tation. In his study, 62% of neuro-SLE patients with posi-
tive antiphospholipid antibody immunoreactivity showed
abnormal hyper-intensity in the white matter on T2-
weighted MR imaging, and this was interpreted as  sugges-
tive of vasculopathy . These data suggest the possibility of
a pathogenic link between abnormal white matter lesions
and antiphospholipid antibodies, though the exact mecha-
nism of tissue injury is not known. Thrombotic occlusion of
small arterioles or venules in the brain, with characteristic
hypercoagulability of the blood, is a plausible explanation.
The other possible mechanism is a non-vascular or non-is-
chemic one, such as direct interaction between antiphos-
pholipid antibodies and cell membrane phospholipid.
Currently, there is no direct evidence to support these hy-
potheses but thrombotic occlusion of cerebral vessels is re-
garded as the most likely mechanism of tissue injury in
PAPS (8 11). 
A large infarct in the territory of the middle cerebral
artery was the second most common finding in our small
series and it may occur due to the thrombosis of cerebral
arteries or embolism from cardiac valvular lesions associat-
ed with PAPS. Arterial thrombosis may be a major cause
of territorial infarct in patients with PAPS (12). Lechner
and Pabinger-Fasching (13) reported a higher prevalence
of arterial thrombosis (25%) in the brain than in other
parts of body (16%), and the special predilection of PAPS
for cerebral arterial thrombosis is now accepted (13, 14). In
other parts of the body, arterial thrombosis appears to be
less prevalent than venous thrombosis which accounts for
more than 70% of PAPS-related thromboses. In the brain,
however, arterial thrombosis is more common than venous
thrombosis, and our own observation lead to this same
conclusion. In some patients with mitral valve vegetations,
however, embolic occlusion of cerebral arteries may occur. 
Diffuse cortical atrophy occurring in PAPS is clinically
associated with dementia. Westerman reported the occlu-
sion of small meningeal and cortical arterioles by thrombi
and marked endothelial hyperplasia in PAPS patients with
dementia (15). These findings suggest that diffuse cortical
atrophy can be caused by multiple cortical infarcts with
thromboses of small arterioles, resulting in dementia (5, 16,
17). 
Dural sinus thrombosis was not a common finding in this
small series. Several PAPS cases with dural sinus thrombo-
Kim et al.
8 Korean J Radiol 1(1), March 2000
Fig. 3. A 34-year-old woman with progressive dementia (case 8).
Axial T1-weighed MR image shows diffuse cerebral atrophy with
prominent sulci and dilatation of the lateral ventricles.sis have been reported (18), and this may be associated
with hypercoaguable condition of the blood in cases in-
volving PAPS. Carhuapoma reported that the presence of
antiphospholipid antibodies was one of the important fac-
tors for the development of dural sinus thrombosis (19). In
PAPS patients, dural sinus thrombosis may occur in a y-
ounger age group and with more extensive involvement of
the venous system than other causes of venous thrombosis
such as pregnancy, hyperviscosity syndrome, Behcet s dis-
ease, coagulopathy including activated protein C resis-
tance, and other collagen vascular diseases. However, the
exact mechanisms by which antiphospholipid antibodies
promote thrombosis remain unknown. Focal hemorrhage
in the basal ganglia was detected in two patients and this
may also be caused the thromboses of small arteries or
venules.
In conclusion, neuroradiologic findings of PAPS include
multiple hyperintense foci in the deep white matter as seen
on T2-weighted MR images, large territorial infarct, diffuse
cortical atrophy, focal hemorrhage, and dural sinus throm-
bosis. Hypercoagulability of the blood and secondary vas-
cular thrombosis appear to be the main pathogenetic mech-
anism leading to various kinds of brain lesions. Although
the neuroradiologic findings are nonspecific, PAPS should
be suspected when young and middle aged adults show the
above mentioned CT or MR findings, and other risk factors
for ischemic stroke or vascular thrombosis are not present. 
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